DRKS00010682已完成不适用
Immunohistochemical examination of the tolerance -inducing enzyme indoleamine 2,3 -dioxygenase ( IDO ) in melanoma as a prognostic marker for progression-free- and overall survival - n/a
niversitätsklinik FreiburgDermatologie und Venerologie0 个研究点目标入组 120 人开始时间: 2016年6月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •available paraffin sections from patients with melanoma +/- sentinel lymph node with tumor thicknesses of less than 1 mm , greater than or equal 4mm and metastasis of melanoma of unknown primary
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Pilot study on tolerability of specific immunotherapywith injective allergoid adsorbed on calcium phosphate in patients with respiratory allergy to house dust mite. - NDallergic rhinoconjunctivitis with or without asthmaMedDRA version: 9.1Level: LLTClassification code 10039085Term: Rhinitis allergicEUCTR2007-003058-26-ITOFARMA
进行中（未招募）
不适用
A Study to Demonstrate Immunogenicity, Tolerability, and Manufacturing Consistency of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered in Preadolescents and Adolescents (9 to 15 year olds), with a Comparison to Young Women (16 to 26 year olds)Cervical CancerEUCTR2009-011617-25-FIMSD Finland Oy2,800
进行中（未招募）
1 期
A Study to Demonstrate Immunogenicity, Tolerability, and Manufacturing Consistency of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered in Preadolescents and Adolescents (9 to 15 year olds), with a Comparison to Young Women (16 to 26 year olds)MedDRA version: 12.0Level: LLTClassification code 10063001Term: Human papilloma virus infectionCervical CancerEUCTR2009-011617-25-ATMerck & Co., Inc.2,800
招募中
不适用
Immunohistochemical and molecular biological examination of VEGFR expression and enhanced pattern of sonazoid-enhanced ultrasonography in patients with metastatic liver tumor originated from colon tumormetastatic liver tumor originated from colon tumorJPRN-UMIN000014858Kobe University Hospital100
进行中（未招募）
不适用
A trial of antigen-specific immune tolerance induction in mucopolysaccharidosis I (MPS I) patients initiating enzyme replacement therapy with Aldurazyme® (laronidase)EUCTR2007-001163-30-Outside-EU/EEAGenzyme, a Sanofi Company12